title: Sentinel lymph node biopsy in management of early breast cancer: Is it rational to omit blue dye injection?
authors.forename: Ahmad
authors.initials: A
authors.lastname: Kaviani
authors.forename: Behnoud Baradaran
authors.initials: BB
authors.lastname: Noveiry
authors.forename: Morteza
authors.initials: M
authors.lastname: Noaparast
mesh_terms: D000707:Anaphylaxis / Q000139:chemically induced; D001943:Breast Neoplasms / Q000473:pathology* / Q000601:surgery*; D003102:Colloids; D004396:Coloring Agents / Q000009:adverse effects; D019468:Disease Management; D005188:False Negative Reactions; D005260:Female; D006801:Humans; D008751:Methylene Blue / Q000009:adverse effects; D009367:Neoplasm Staging; D021701:Sentinel Lymph Node Biopsy / Q000379:methods*
chemical_list: D003102:Colloids; D004396:Coloring Agents; D008751:Methylene Blue